SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-105216
Filing Date
2021-04-02
Accepted
2021-04-02 16:59:28
Documents
8
Effectiveness Date
2021-04-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR d130369ds3asr.htm S-3ASR 386218
2 EX-1.2 d130369dex12.htm EX-1.2 198232
3 EX-4.3 d130369dex43.htm EX-4.3 35991
4 EX-4.4 d130369dex44.htm EX-4.4 264989
5 EX-5.1 d130369dex51.htm EX-5.1 35513
6 EX-23.1 d130369dex231.htm EX-23.1 1812
7 GRAPHIC g130369g61j23.jpg GRAPHIC 32072
8 GRAPHIC g130369logo.jpg GRAPHIC 7474
  Complete submission text file 0001193125-21-105216.txt   978610
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-255014 | Film No.: 21802677
SIC: 2836 Biological Products, (No Diagnostic Substances)